Armistice Capital’s Cadrenal Therapeutics CVKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-89,972
Closed -$823K 285
2024
Q1
$823K Buy
89,972
+62,353
+226% +$571K 0.01% 169
2023
Q4
$307K Sell
27,619
-37,867
-58% -$420K ﹤0.01% 214
2023
Q3
$668K Buy
+65,486
New +$668K 0.01% 154